ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Brenus Pharma secured €11 million in a Series A extension funding round. The financing will support the company's development of cancer vaccine therapies. The round included participation from existing and new investors.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
Augustus Raises $180M Series B